is this you? Claim your profile.
is this you? Claim your profile.
Director of Breast Cancer Treatment and Prevention At the Carol G. Simon Cancer Center
HQ Phone:  (908) 522-2133
+ Get 10 Free Contacts a Month
It's free and takes 30 seconds
99 Beauvoir Avenue
Summit, New Jersey,07901
The Ta Ta Book Club
State University of New York at Stonybrook
Bonni Guerin, MD at Medical Diagnostic Associates Oncology & Hematology
Bonni Guerin, MD
Bonni Guerin, MD Bonni Guerin, MD Bonni L. Guerin, a medical oncologist with 20 years of experience, is dedicated to providing the most up to date, cutting edge treatment while looking at each of her patients as an individual. Her philosophy is one of collaboration, working with all members of the care team to provide the best outcome possible. Dr. Guerin believes that compassion and being a good listener, traits she learned from her mother, help tailor a treatment plan that reflects not only the highest order of medical care, but also one that uniquely reflects each and every patient. Dr. Guerin believes it is just as much about living well as it is living long. Dr. Guerin currently serves as the Director of Breast Cancer Treatment and Prevention at the Carol G. Simon Cancer Center at Overlook Medical Center. She is the principal investigator of numerous clinical trials exploring new ways to incorporate the latest advances in the management of breast cancer. She completed her residency at Vanderbilt University and her fellowship training at the University of California in San Diego. She is board certified in medical oncology and has advanced specialized expertise in the management of breast diseases. She is also actively involved in the delivery of highly-specialized immunotherapy, IL-2, for the treatment of melanoma and kidney cancer. Dr. Guerin currently is the director of Breast Cancer Treatment and Prevention at the Carol G. Simon Cancer Center at Overlook Medical Center. She has been named by Castle Connelly as one of NY/Metro Top Doctors for the last 8 years, as well as a Top Doctor for Women's Health. She has recently been honored by Curemonos, a New Jersey non-profit organization dedicated to supporting medically underserved women with breast cancer, and was the keynote speaker at the American Cancer Society Relay for Life in Chatham NJ. Dr. Guerin has also served as the Chair, Women's Oncology Forum, Network for Oncology Communication and Research. Bonni Guerin, MD
Bonni Lee Guerin MD, Hematologist/Oncologist at Medical Diagnostic Associates, a Multi-Specialty Medical Group in Central New Jersey
Bonni Lee Guerin, MD
> Bonni Lee Guerin, MD Bonni Lee Guerin, MD Dr. Bonni Guerin, Medical Diagnostic Associates Dr. Guerin is the Director of Oncology Education and the High-Dose Interleukin II Program at Overlook Hospital. She also serves as the Chair of the Multidisciplinary Breast Conference at Overlook Hospital and the Women's Oncology Forum of the Network for Oncology Communication and Research.
According to Dr. Bonni Guerin, Director of Breast Cancer Treatment & Prevention at Overlook Hospital in Summit, "Across the board, 75 percent of breast cancer patients are cured, however for those women who have had a lumpectomy or mastectomy -- even if they have been told that all of the cancer has been removed -- about 15 to 20 percent will have a recurrence," Guerin said.
For women with a recurrence of breast cancer, the mortality rate is 99 to 100 percent, Guerin said. She said traditionally chemotherapy has been administered to all women with breast cancer, but chemotherapy doesn't work on all types of breast cancer. "The Tailorx 1 trial proved very effective in predicting who had tumors that were sensitive to chemotherapy and those who had tumors that were deaf to chemotherapy," said Guerin. For example, two women of the same age and general health who had small tumors removed have different chances of a recurrence, Guerin said. "The Oncotype test can now tell us that Jane has genetic material that couldn't find its way out of a paper bag if it tried -- meaning it is not likely to spread and therefore needs no chemotherapy," said Guerin. "It can also tell us whether Sally has a tumor with genetic material that codes for protein and teaches cells how to replicate and break off and enter into the blood stream. And so for Sally, the test tells me chemotherapy is a must," said Guerin.
Ta-ta Book Club
The Ta Ta Book Club was founded by Bonni Guerin, MD - Chair of the Breast Panel at the Overlook Cancer Center.
She studied medicine at the State University of New York at Stonybrook. Dr. Bonni Guerin Director, Oncology Education, Overlook Hospital, 2004-Present Director, High-Dose Interleukin II Program, Overlook Hospital, 2004-Present
Dr. Bonni Guerin, oncologist at the Carol G. Simon Cancer Center at Overlook Hospital in Summit and director of the hospital's Multidisciplinary Breast Conference, named several risk factors.
Most relate to life events that maximize ovulation, which produces estrogen to rebuild the uterine lining after menstruation. "Risks for breast cancer include if you had an early first period; if you never had a child; if you had a child later in life; if you had a late menopause; if you had more than 10 years of high-dose estrogen, such as in birth control pills; and if you used hormone replacement therapy," she said. According to Guerin, only 5 percent of all breast cancers are associated with the genes, which are especially but not exclusively found in people with Ashkenazi Jewish, Icelandic, Norwegian and Dutch backgrounds. "BRCA positivity doesn't necessarily mean the cancer you get is worse, but it does mean that you have a greater tendency to get it," Guerin said. "I've read risks as low as 30 percent and as high as 80 percent." The average age for breast cancer in this country is 55 years old, she added. "But for BRCA, it's younger," Guerin said. "So if any 32-year-old woman -- and not just Ashkenazi Jewish women -- walks into my office, and she has breast cancer, she's getting BRCA tested because that's just not right." Another natural candidate for the $3,000 test, which can be conducted with blood or saliva, is someone who has bilateral breast cancer, meaning cancer in both breasts. At Overlook Hospital, Guerin has helped develop a prevention program for all patients -- not just high-risk patients -- that encompasses a three-hour analysis of genetics, diet and lifestyle as well as a clinical exam and a digital mammogram with computer-assisted detection read by a specially trained breast-image reader. Other technologies are included, as needed.